News & Perspectives

Transforming our approach to patient advocacy

Global Patient Outreach Vice President Jasmine Greenamyer shares how patient advocacy works to meet the evolving needs of patients

September 19, 2024     

Keeping patients at the center of what we do — we hear this often, but exactly how is Bristol Myers Squibb doing that? Our Global Patient Outreach (GPO) team plays a key role in helping to ensure we make good on our promise to put patients first.

In recognition of Global Patient Week, Jasmine Greenamyer, vice president, Global Patient Outreach, discusses how the GPO team infuses patients’ lived experiences into every aspect of their work.
 

How is the Global Patient Outreach team organized?

The GPO team is comprised of three pillars ― bringing together the Patient Advocacy team, the Patient Experience team, and the Patient Voice team. Each pillar plays a crucial role in ensuring that the patient's perspective is at the forefront of our decision-making processes. 
 

How does this team stay connected to the evolving needs and challenges of patients worldwide? 

Our strategy is really a combination of direct feedback from the patient communities we serve, the patient advocates we work with and being present at larger forums to gain additional knowledge. From industry councils to advisory boards like the patient expert engagement resource (PEER) – we’re able to connect directly with patient experts and get feedback on anything from packaging to the health literacy of something we’re launching. Being able to hear from our peers and learn some of the best practices that they’ve implemented is also incredibly helpful in understanding patient challenges, which is something we take seriously. 

Jasmine Greenamyer

Can you share an initiative that has been particularly impactful for patient communities? 

When I think of an initiative with the most impact, I think about the advocacy team’s work around hypertrophic cardiomyopathy (HCM). 

In 2021, BMS was a sponsor of the Global Heart Hub’s cardiomyopathy patient council with the goal of creating a global alliance to increase awareness and understanding of cardiomyopathies. The council started with three patient organizations and grew to 30 different organizations. 

Fast forward – the program is now available in 10 languages, in 12 different countries. So, you can see the high level of need was there and these resource materials have literally changed patient lives while helping the patient communicate better about their condition. 

How do you know what you’re doing is working within patient communities?

We’re looking to see if we’ve increased education and patient empowerment, if we’ve increased understanding of the latest science and research, and one of the questions we ask ourselves long-term is, did we help increase access to treatment for our patients? Our success is interdependent with many other parts of the business. 

We also invest every two years in a reputational qualitative research study where we get feedback from our advocacy groups. We want their perception of how BMS patient advocacy is doing, and we also want them to rate us compared to our peers. It’s very informative and helps set our benchmarks. 

How do you ensure that diverse patient populations are represented, and their unique needs are addressed?

We try to look at what the specific patient groups need, but we also try to go above a specific therapeutic area to make sure we are working with communities that are under-supported. One of the ways we achieve this is by working  with our People and Business Resource Groups. I have found this particularly valuable because they possess greater cultural expertise and are often already engaged in direct work with the patient community or advocacy organizations. 

That’s one way we help to make sure  diverse populations are represented. Additionally, we believe that the valuable expertise provided by our local advocacy leaders is crucial to achieving our diversity goals.

Global Patient Outreach Fast Facts

The GPO team is comprised of three pillars

  • Patient Advocacy
  • Patient Experience
  • Patient Voice

What is a patient expert vs. a patient advocate?
 

The two titles can often be interchangeable.

  • Patient advocates
    Support and promote the interests and rights of patients.

  • Patient experts:
    Have more formal experience and training advocating on behalf of the patient community. 


Subscribe to Our stories alerts
 

Beyond just relevant information about Bristol Myers Squibb's therapeutic areas and innovation, Our stories offer a window into the work our employees do every day for patients.


About Bristol Myers Squibb

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. As global citizens, we work sustainably and responsibly to create a positive impact in the communities where we live and work.